Chromadex Corp Valuation
| CDXC Stock | USD 7.72 0.08 1.05% |
At this time, the firm appears to be overvalued. Chromadex Corp shows a prevailing Real Value of $6.52 per share. The current price of the firm is $7.72. Our model approximates the value of Chromadex Corp from analyzing the firm fundamentals such as Return On Equity of 0.0482, profit margin of 0.02 %, and Current Valuation of 554.22 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Chromadex Corp's valuation include:
Price Book 16.9795 | Enterprise Value 554.2 M | Enterprise Value Ebitda 284.7981 | Price Sales 6.4328 | Forward PE 58.8235 |
Overvalued
Today
Please note that Chromadex Corp's price fluctuation is risky at this time. Calculation of the real value of Chromadex Corp is based on 3 months time horizon. Increasing Chromadex Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Chromadex Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chromadex Stock. However, Chromadex Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.72 | Real 6.52 | Target 5.17 | Hype 7.99 | Naive 6.71 |
The real value of Chromadex Stock, also known as its intrinsic value, is the underlying worth of Chromadex Corp Company, which is reflected in its stock price. It is based on Chromadex Corp's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Chromadex Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Chromadex Corp helps investors to forecast how Chromadex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chromadex Corp more accurately as focusing exclusively on Chromadex Corp's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Chromadex Corp's intrinsic value based on its ongoing forecasts of Chromadex Corp's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Chromadex Corp's closest peers. If more than one evaluation category is relevant for Chromadex Corp we suggest using both methods to arrive at a better estimate.
Chromadex Corp Cash |
|
Chromadex Valuation Trend
Comparing Chromadex Corp's enterprise value against its market capitalization is a good way to estimate the value of Chromadex Corp uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Chromadex Revenue by Product
Chromadex Corp Total Value Analysis
Chromadex Corp is currently anticipated to have valuation of 554.22 M with market capitalization of 589.68 M, debt of 3.28 M, and cash on hands of 16.87 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Chromadex Corp fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
554.22 M | 589.68 M | 3.28 M | 16.87 M |
Chromadex Corp Investor Information
About 35.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Chromadex Corp had 1:3 split on the 13th of April 2016. Based on the analysis of Chromadex Corp's profitability, liquidity, and operating efficiency, Chromadex Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Chromadex Corp Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Chromadex indicates not a very effective usage of assets in November.Chromadex Corp Ownership Allocation
Chromadex Corp holds a total of 76.38 Million outstanding shares. Chromadex Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Chromadex Corp Profitability Analysis
The company reported the previous year's revenue of 83.57 M. Net Loss for the year was (4.94 M) with profit before overhead, payroll, taxes, and interest of 42.8 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chromadex Corp's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chromadex Corp and how it compares across the competition.
About Chromadex Corp Valuation
The stock valuation mechanism determines Chromadex Corp's current worth on a weekly basis. Our valuation model uses a comparative analysis of Chromadex Corp. We calculate exposure to Chromadex Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chromadex Corp's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 50.8 M | 53.3 M | |
| Pretax Profit Margin | (0.06) | (0.06) | |
| Operating Profit Margin | (0.07) | (0.07) | |
| Net Loss | (0.06) | (0.06) | |
| Gross Profit Margin | 0.61 | 0.35 |
Chromadex Corp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 75 M | |
| Forward Price Earnings | 58.8235 |
Chromadex Corp Current Valuation Indicators
Valuation refers to the process of determining the present value of Chromadex Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Chromadex we look at many different elements of the entity such as Chromadex's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Chromadex Corp, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Chromadex Corp's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Chromadex Corp's worth.Complementary Tools for Chromadex Stock analysis
When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |